Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Myomo Inc (NY: MYO )

3.620 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, May 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.620
Bid (Size) 3.660 (17)
Ask (Size) 4.100 (55)
Prev. Close 3.620
Today's Range 3.620 - 3.620
52wk Range 0.3710 - 5.580
Shares Outstanding 20,923,417
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees
From Myomo, Inc.
Via Business Wire
Myomo to Report First Quarter Financial Results on May 8, 2024
From Myomo, Inc.
Via Business Wire

Performance

YTD
-24.43%
-24.43%
1 Month
+15.29%
+15.29%
3 Month
-5.97%
-5.97%
6 Month
+105.68%
+105.68%
1 Year
+596.15%
+596.15%

More News

Read More
Myomo Appoints Heather Getz to its Board of Directors
From Myomo, Inc.
Via Business Wire
Recap: Myomo Q4 Earnings
Via Benzinga
Myomo Earnings Preview
Via Benzinga
Myomo: Q3 Earnings Insights
Via Benzinga
Earnings Outlook For Myomo
Via Benzinga
MYO Stock Earnings: Myomo Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Myomo Reports Fourth Quarter and Full Year 2023 Financial Results
From Myomo, Inc.
Via Business Wire
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Earnings Scheduled For March 7, 2024
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro®
From Myomo, Inc.
Via Business Wire
Myomo to Report Fourth Quarter Financial Results on March 7, 2024
From Myomo, Inc.
Via Business Wire
Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
From Myomo, Inc.
Via Business Wire
Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
From Myomo, Inc.
Via Business Wire
Myomo Reports Preliminary Fourth Quarter Revenue and Backlog
From Myomo, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Inside: 1 Of My Top 3 Picks For 2024
Via Talk Markets
7 Stock Winners That Are Up 1,000% or More in 2023
Via InvestorPlace
3 Hot Penny Stocks to Buy in Q4 for Promising Potential
Via InvestorPlace
Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations
From Myomo, Inc.
Via Business Wire
CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting
From Myomo, Inc.
Via Business Wire
Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category
From Myomo, Inc.
Via Business Wire
Myomo to Report Third Quarter Financial Results on November 7, 2023
From Myomo, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.